Advertisement

Topics

Bausch & Lomb Incorporated Company Profile

13:15 EDT 20th March 2019 | BioPortfolio

Bausch & Lomb is the preeminent global technology based healthcare company for the eye, dedicated to helping consumers see, look and feel better through innovative technology and design. The company is building on that position through expansion of its current eye care businesses, as well as the pursuit of promising new opportunities within the global eye care market.

Bausch & Lomb manages its commercial operations on a regional basis and the research and development and product supply functions are managed on a global basis. The company markets five broad categories of products:



Contact Lenses: Sales of contact lenses represented approximately 28% of consolidated 2001 revenues. The company's contact lens offerings span the entire spectrum of wearing modalities and include such well known brand names as PureVision, SofLens66 Toric, SofLens One Day, Bausch & Lomb Two Week, Boston and Optima FW.

Lens Care: The sale of contact lens care solutions represented approximately 25% of consolidated 2001 revenues. The company’s lens care products include the ReNu and Sensitive Eyes brands for soft contact lenses and the Boston line of products for cleaning rigid gas permeable contact lenses.



Cataract and Vitreoretinal Surgery: Products used for cataract and vitreoretinal surgery procedures accounted for approximately 18% of consolidated 2001 revenues. The company offers a full suite of products in this area, including various intraocular lenses and delivery systems, the Millennium line of phacoemulsification equipment, and other surgical devices and instruments.

Refractive Surgery: Sales of products used in refractive surgery accounted for approximately 8% of consolidated 2001 revenues. Offerings in this area include the Technolas 217 small-beam advanced scanning excimer laser, the Hansatome microkeratome, the Orbscan corneal topographer and, outside the U.S., the Zyoptix system for customized laser vision correction.



Pharmaceutical: Sales of pharmaceutical products accounted for approximately 21% of consolidated 2001 revenues. The company’s offerings include generic and proprietary prescription pharmaceuticals, mostly in the ophthalmic field, over-the-counter eye drops and other medications. During 2000 the company expanded its presence in this area through the acquisition of Groupe Chauvin, a French ophthalmic pharmaceutical company. In combination with the company's existing Dr. Mann Pharma business in Germany, the acquisition will provide a pan-European presence and infrastructure from which to launch new products in development as well as to expand the distribution of the company's current proprietary pharmaceutical products, such as Lotemax and Alrex.

Location

One Bausch & Lomb Place
Rochester
NY
14604
United States of America

Contact

Phone: 716 338 6000


News Articles [89 Associated News Articles listed on BioPortfolio]

Bausch & Lomb gets US rights to Eton's Phase III ophthalmic candidate

Bausch Health Companies Inc.’s Bausch & Lomb Inc. acquired US rights to Eton Pharmaceuticals Inc.’s EM100, a Phase III eye drop formulation for allergic conjunctivitis.

New formulation of Bausch & Lomb's Lotemax approved by FDA

Bausch & Lomb's Lotemax SM, or loteprednol etabonate ophthalmic gel 0.38%, a new formulation, has been approved by the FDA fo -More- 

FDA approves Bausch + Lomb’s ophthalmic gel for postoperative inflammation and pain

Lotemax SM takes the support of SubMicron (SM) technology to adhere to the ocular surface and then access crucial ocular tissues. The new gel delivers a submicron particle The post FDA approves Bausc...

FDA approves Bausch + Lomb’s Lotemax SM for postoperative inflammation, pain

Lotemax SM takes the support of SubMicron (SM) technology to adhere to the ocular surface and then access crucial ocular tissues. The new gel delivers a submicron particle The post FDA approves Bausc...

Bausch Lomb Incorporated Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 28072018] Prices from USD $350

Bausch Lomb Incorporated Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Bausch Lomb Incorporated Mergers Acquisitions MA, Partnerships Alliances and In...

FDA Approves Lotemax SM For Ocular Surgery Pain, Inflammation

The FDA has approved a new formulation of loteprednol etabonate ophthalmic gel (Lotemax SM, Bausch + Lomb) 0.38% for postoperative inflammation and pain following ocular surgery. FDA Approvals

Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer ...

LAVAL, Quebec, Nov. 21, 2018 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health," the "Company" or the "Offeror") announced today the results to Read more...

Bausch Health to buy certain assets of Synergy Pharmaceuticals

“As we continue to transform Bausch Health, we are now pivoting to offense with research investments and strategic acquisitions that augment our core businesses. We are excited to The post Baus...

Drugs and Medications [233 Associated Drugs and Medications listed on BioPortfolio]

Bacitracin zinc and polymyxin b sulfate [bausch & lomb incorporated]

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP (Sterile)

Proparacaine hydrochloride [bausch & lomb incorporated]

Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (Sterile)

Tropicamide [bausch & lomb incorporated]

Tropicamide Ophthalmic Solution, USP (Sterile)

Bacitracin zinc and polymyxin b sulfate [rebel distributors corp]

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP (Sterile)

Bacitracin zinc and polymyxin b sulfate [a-s medication solutions]

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP (Sterile)

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Long-acting intraocular delivery strategies for biological therapy of age-related macular degeneration.

As one of the leading causes of central vision loss in elderly population, worldwide cases of age-related macular degeneration (AMD) have seen a dramatic increase over the past several years. Treatmen...

Increased dNTP pools rescue mtDNA depletion in human POLG-deficient fibroblasts.

Polymerase γ catalytic subunit ( POLG) gene encodes the enzyme responsible for mitochondrial DNA (mtDNA) synthesis. Mutations affecting POLG are the most prevalent cause of mitochondrial disease beca...

Clinical Trials [22 Associated Clinical Trials listed on BioPortfolio]

Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)

A Study to Document the Safety and Effectiveness of a New OVD When Compared to a Control OVD

Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens

This study is to evaluate the safety and effectiveness of the Bausch & Lomb Akreos TL intraocular lens following implantation in adults requiring cataract surgery.

Performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a New Packaging Configuration

The objective of the study is to evaluate the product performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a new packaging configuration

A Study to Evaluate the Clinical Performance of a Novel Multipurpose Solution

The objective of this study is to evaluate the clinical performance of Bausch & Lomb investigational Multi-Purpose Solution compared to Ciba Vision Multi-Purpose Solution when used by wear...

Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos Advanced Optics Intraocular Lens Implantation

Purpose: To determine whether implantation of an intraocular lens (IOL) with a modified anterior and posterior aspherical surface (Akreos AO, Bausch & Lomb,Inc) results in reduced ocular a...

Companies [47 Associated Companies listed on BioPortfolio]

Bausch & Lomb

Bausch & Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pha...

Bausch & Lomb, Inc.

Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life.We offer the world’s most comprehensive portfolio of eye health products and we’re proud that ours is one ...

Bausch + Lomb and Cirle

Bausch + Lomb, a Valeant Pharmaceuticals North America LLC company, is a leading global eye health organization that is solely focused on protecting, enhancing, and restoring peop...

Bausch & Lomb Incorporated

Bausch & Lomb is the preeminent global technology based healthcare company for the eye, dedicated to helping consumers see, look and feel better through innovative technology and design. The company i...

BAUSCH-STROBEL Machine Company, Inc

With this clearly defined company goal in mind, we design, build and sell packaging and production systems for the pharmaceutical, cosmetic and chemical industries. From modest beginnings to 40 years ...

More Information about "Bausch & Lomb Incorporated" on BioPortfolio

We have published hundreds of Bausch & Lomb Incorporated news stories on BioPortfolio along with dozens of Bausch & Lomb Incorporated Clinical Trials and PubMed Articles about Bausch & Lomb Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bausch & Lomb Incorporated Companies in our database. You can also find out about relevant Bausch & Lomb Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...


Corporate Database Quicklinks



Searches Linking to this Company Record